Zynerba Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q1 2016 to Q2 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Zynerba Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2016 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Current Ratio for the quarter ending June 30, 2023 was 510 %, a 34.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 510 -272 -34.8% Jun 30, 2023
Q1 2023 606 -244 -28.7% Mar 31, 2023
Q4 2022 687 -170 -19.9% Dec 31, 2022
Q3 2022 741 -29.2 -3.79% Sep 30, 2022
Q2 2022 783 +35.4 +4.74% Jun 30, 2022
Q1 2022 850 +170 +25.1% Mar 31, 2022
Q4 2021 857 +212 +32.8% Dec 31, 2021
Q3 2021 770 +68.8 +9.81% Sep 30, 2021
Q2 2021 747 -16.5 -2.17% Jun 30, 2021
Q1 2021 680 -160 -19.1% Mar 31, 2021
Q4 2020 645 -253 -28.1% Dec 31, 2020
Q3 2020 701 -199 -22.1% Sep 30, 2020
Q2 2020 764 -82.7 -9.77% Jun 30, 2020
Q1 2020 840 +141 +20.2% Mar 31, 2020
Q4 2019 898 +267 +42.3% Dec 31, 2019
Q3 2019 901 +227 +33.6% Sep 30, 2019
Q2 2019 846 +159 +23.1% Jun 30, 2019
Q1 2019 699 -145 -17.2% Mar 31, 2019
Q4 2018 631 -350 -35.6% Dec 31, 2018
Q3 2018 674 -217 -24.4% Sep 30, 2018
Q2 2018 688 -180 -20.7% Jun 30, 2018
Q1 2018 844 +44.9 +5.62% Mar 31, 2018
Q4 2017 981 +246 +33.4% Dec 31, 2017
Q3 2017 891 -18.4 -2.02% Sep 30, 2017
Q2 2017 867 -259 -23% Jun 30, 2017
Q1 2017 799 -210 -20.8% Mar 31, 2017
Q4 2016 735 Dec 31, 2016
Q3 2016 909 Sep 30, 2016
Q2 2016 1.13K Jun 30, 2016
Q1 2016 1.01K Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.